These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 33904352

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S, Kohlmann A, Schnittger S, Kern W, Haferlach T, Haferlach C.
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [Abstract] [Full Text] [Related]

  • 3. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup.
    Hong M, Hao S, Patel KP, Kantarjian HM, Garcia-Manero G, Yin CC, Medeiros LJ, Lin P, Lu X.
    Cancer Genet; 2016 May; 209(5):205-14. PubMed ID: 27134073
    [Abstract] [Full Text] [Related]

  • 4. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
    Rossi G, Pelizzari AM, Bellotti D, Tonelli M, Barlati S.
    Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
    Niparuck P, Police P, Noikongdee P, Siriputtanapong K, Limsuwanachot N, Rerkamnuaychoke B, Chuncharunee S, Siriboonpiputtana T.
    Diagn Pathol; 2021 Oct 31; 16(1):100. PubMed ID: 34717674
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.
    Ren Y, Wang J, Zhang H, Mei C, Ye L, Luo Y, Zhou X, Zhu S, Jiang L, Wang L, Jin J, Tong H.
    Asia Pac J Clin Oncol; 2020 Jun 31; 16(3):172-179. PubMed ID: 32030889
    [Abstract] [Full Text] [Related]

  • 10. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype.
    Huh YO, Tang G, Talwalkar SS, Khoury JD, Ohanian M, Bueso-Ramos CE, Abruzzo LV.
    Cancer Genet; 2016 Jun 31; 209(7-8):313-20. PubMed ID: 27318442
    [Abstract] [Full Text] [Related]

  • 11. [The Genetic and Prognostic Characteristics of AML-MRC Patients].
    Chen Z, Mu QT, Wu A, Ouyang GF.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb 31; 30(1):18-21. PubMed ID: 35123598
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
    Becker H, Pfeifer D, Ihorst G, Pantic M, Wehrle J, Rüter BH, Bullinger L, Hackanson B, Germing U, Kuendgen A, Platzbecker U, Döhner K, Ganser A, Hagemeijer A, Wijermans PW, Döhner H, Duyster J, Lübbert M.
    Ann Hematol; 2020 Jul 31; 99(7):1551-1560. PubMed ID: 32504186
    [Abstract] [Full Text] [Related]

  • 15. TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups.
    Haase D, Stevenson KE, Neuberg D, Maciejewski JP, Nazha A, Sekeres MA, Ebert BL, Garcia-Manero G, Haferlach C, Haferlach T, Kern W, Ogawa S, Nagata Y, Yoshida K, Graubert TA, Walter MJ, List AF, Komrokji RS, Padron E, Sallman D, Papaemmanuil E, Campbell PJ, Savona MR, Seegmiller A, Adès L, Fenaux P, Shih LY, Bowen D, Groves MJ, Tauro S, Fontenay M, Kosmider O, Bar-Natan M, Steensma D, Stone R, Heuser M, Thol F, Cazzola M, Malcovati L, Karsan A, Ganster C, Hellström-Lindberg E, Boultwood J, Pellagatti A, Santini V, Quek L, Vyas P, Tüchler H, Greenberg PL, Bejar R, International Working Group for MDS Molecular Prognostic Committee.
    Leukemia; 2019 Jul 31; 33(7):1747-1758. PubMed ID: 30635634
    [Abstract] [Full Text] [Related]

  • 16. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
    Britt A, Mohyuddin GR, McClune B, Singh A, Lin T, Ganguly S, Abhyankar S, Shune L, McGuirk J, Skikne B, Godwin A, Pessetto Z, Golem S, Divine C, Dias A.
    Leuk Res; 2020 Aug 31; 95():106402. PubMed ID: 32590108
    [Abstract] [Full Text] [Related]

  • 17. Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.
    Devillier R, Mansat-De Mas V, Gelsi-Boyer V, Demur C, Murati A, Corre J, Prebet T, Bertoli S, Brecqueville M, Arnoulet C, Recher C, Vey N, Mozziconacci MJ, Delabesse E, Birnbaum D.
    Oncotarget; 2015 Apr 10; 6(10):8388-96. PubMed ID: 25860933
    [Abstract] [Full Text] [Related]

  • 18. [Clinical Characteristics and Karyotype Analysis of Myelodysplastic Syndrome Patients with TP53 mutation].
    Zhou XY, Ouyang GF, Mu QT, Sheng LX.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun 10; 27(3):872-876. PubMed ID: 31204947
    [Abstract] [Full Text] [Related]

  • 19. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
    Sebaa A, Ades L, Baran-Marzack F, Mozziconacci MJ, Penther D, Dobbelstein S, Stamatoullas A, Récher C, Prebet T, Moulessehoul S, Fenaux P, Eclache V.
    Genes Chromosomes Cancer; 2012 Dec 10; 51(12):1086-92. PubMed ID: 22933333
    [Abstract] [Full Text] [Related]

  • 20. Molecular characterization and prognosis of mutant TP53 acute myeloid leukemia and myelodysplastic syndrome with excess blasts.
    Shen K, Hu DY, Zhang ZB, Guo YS, Zhang FH, Chen SN.
    Int J Lab Hematol; 2023 Jun 10; 45(3):344-352. PubMed ID: 36860196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.